BEPAFANT, (R)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H22ClN5O2S
Molecular Weight	467.971
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=NN=C2CN=C(C3=C(SC4=C3C[C@H](C4)C(=O)N5CCOCC5)N12)C6=CC=CC=C6Cl

InChI

InChIKey=FWYVRZOREBYLCY-CQSZACIVSA-N

InChI=1S/C23H22ClN5O2S/c1-13-26-27-19-12-25-21(15-4-2-3-5-17(15)24)20-16-10-14(11-18(16)32-23(20)29(13)19)22(30)28-6-8-31-9-7-28/h2-5,14H,6-12H2,1H3/t14-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C23H22ClN5O2S
Molecular Weight	467.971
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 20:57:57 GMT 2025` Edited by `admin` on `Mon Mar 31 20:57:57 GMT 2025`
Record UNII	G1VX7M539J
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BEPAFANT, (R)-

Common Name

English

MORPHOLINE, 4-((6-(2-CHLOROPHENYL)-8,9-DIHYDRO-1-METHYL-4H,7H-CYCLOPENTA(4,5)THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-8-YL)CARBONYL)-, (R)-

Preferred Name

English

Code System Code Type Description

CAS

114800-16-7

Created by admin on Mon Mar 31 20:57:57 GMT 2025 , Edited by admin on Mon Mar 31 20:57:57 GMT 2025

PRIMARY

FDA UNII

G1VX7M539J

Created by admin on Mon Mar 31 20:57:57 GMT 2025 , Edited by admin on Mon Mar 31 20:57:57 GMT 2025

PRIMARY

PUBCHEM

14071229

Created by admin on Mon Mar 31 20:57:57 GMT 2025 , Edited by admin on Mon Mar 31 20:57:57 GMT 2025

PRIMARY

Related Record Type Details


					CKS724B66O

BEPAFANT

RACEMATE -> ENANTIOMER